Observational Study to Evaluate Fertility in Women Aged 32 to 38 Using Ovosicare4 Fertility Food Supplement Containing MYO/DCI, Antioxidants, Vitamins, and Minerals

What this Trial Is About

This research aims to evaluate whether taking the Ovosicare4 Fertility food supplement helps increase the chance of becoming pregnant in women aged 32 to 38 years who have been trying to conceive for at least six months before starting supplementation. The study is observational and focuses on real-world use of this supplement containing a combination of MYO/DCI, antioxidants, vitamins, and minerals. Participants will follow a supplementation plan prescribed as part of standard clinical practice. The study does not require additional tests or extraordinary visits beyond those normally done in routine care. The observation period for each participant will last up to 18 months, but it may end sooner if pregnancy occurs. During the study, there will be a total of three visits. Women in the study will undergo routine assessments including blood tests for biochemical and hormonal panels, karyotype analysis, and ultrasound exams to monitor anatomy and follicle count. Researchers will track spontaneous pregnancy rates, time until pregnancy, safety, tolerability, satisfaction, and adherence to supplementation. Live birth rates will also be recorded after pregnancy confirmation. The study provides follow-up through 9 months after enrollment or until pregnancy.

Observational Study to Evaluate Fertility in Women Between 32 and 38 Years Old Treated With the Ovosicare® Fertility